# Cyclobenzaprine Hydrochloride

NDC: 33342-272
Generic name: Cyclobenzaprine Hydrochloride
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20240722

FDA application: ANDA207314

## Active ingredients

- CYCLOBENZAPRINE HYDROCHLORIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-272"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-272
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1af467cb-7b21-4084-bb54-4634e928b167